Different GATA factors dictate CCR3 transcription in allergic inflammatory cells in a cell type-specific manner

Journal of Immunology

Volumn 190, Issue 11, 2013, Pages 5747-5756

  Kong, Su Kang ^a   Kim, Byung Soo ^a   Uhm, Tae Gi ^a   Lee, Wonyong ^b   Lee, Gap Ryol ^b   Park, Choon Sik ^c   Lee, Chul Hoon ^a   Chung, Il Yup ^a  

^a Hanyang University   (South Korea)

^b Sogang University   (South Korea)

^c Soonchunhyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR3; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR GATA; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR GATA 3;

ALLERGIC INFLAMMATORY CELL; ALLERGY; ARTICLE; CELL DIFFERENTIATION; CELL SPECIFICITY; CELL TYPE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EOSINOPHIL; GEL MOBILITY SHIFT ASSAY; GENE ACTIVITY; HUMAN; HUMAN CELL; INFLAMMATORY CELL; LEUKEMIA CELL LINE; MAST CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REPORTER GENE; RNA INTERFERENCE; TH2 CELL; TRANSCRIPTION REGULATION; UMBILICAL CORD BLOOD;

BINDING SITES; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; EOSINOPHILS; FETAL BLOOD; GATA TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GENE ORDER; GENE SILENCING; HUMANS; HYPERSENSITIVITY; MAST CELLS; ORGAN SPECIFICITY; PROTEIN BINDING; RECEPTORS, CCR3; RNA INTERFERENCE; TH2 CELLS; TRANSCRIPTION, GENETIC;

EID: 84878063178     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203542     Document Type: Article

References (59)

1. Daugherty, B. L., S. J. Siciliano, J. A. DeMartino, L. Malkowitz, A. Sirotina, and M. S. Springer. 1996. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J. Exp. Med. 183: 2349-2354. (Pubitemid 26158926)
2. Ponath, P. D., S. Qin, T. W. Post, J. Wang, L. Wu, N. P. Gerard, W. Newman, C. Gerard, and C. R. Mackay. 1996. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J. Exp. Med. 183: 2437-2448. (Pubitemid 26192353)
3. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277: 2005-2007. (Pubitemid 27449145)
4. Romagnani, P., A. De Paulis, C. Beltrame, F. Annunziato, V. Dente, E. Maggi, S. Romagnani, and G. Marone. 1999. Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. Am. J. Pathol. 155: 1195-1204. (Pubitemid 29488927)
5. Stellato, C., M. E. Brummet, J. R. Plitt, S. Shahabuddin, F. M. Baroody, M. C. Liu, P. D. Ponath, and L. A. Beck. 2001. Expression of the C-C chemokine receptor CCR3 in human airway epithelial cells. J. Immunol. 166: 1457-1461. (Pubitemid 32114623)
6. Beck, L. A., B. Tancowny, M. E. Brummet, S. Y. Asaki, S. L. Curry, M. B. Penno, M. Foster, A. Bahl, and C. Stellato. 2006. Functional analysis of the chemokine receptor CCR3 on airway epithelial cells. J. Immunol. 177: 3344- 3354.
7. Takeda, A., J. Z. Baffi, M. E. Kleinman, W. G. Cho, M. Nozaki, K. Yamada, H. Kaneko, R. J. Albuquerque, S. Dridi, K. Saito, et al. 2009. CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature 460: 225- 230.
8. Orkin, S. H. 1992. GATA-binding transcription factors in hematopoietic cells. Blood 80: 575-581.
9. Evans, T., and G. Felsenfeld. 1989. The erythroid-specific transcription factor Eryf1: a new finger protein. Cell 58: 877-885. (Pubitemid 19227897)
10. Tsai, S. F., D. I. Martin, L. I. Zon, A. D. D'Andrea, G. G. Wong, and S. H. Orkin. 1989. Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells. Nature 339: 446-451.
11. Romeo, P. H., M. H. Prandini, V. Joulin, V. Mignotte, M. Prenant, W. Vainchenker, G. Marguerie, and G. Uzan. 1990. Megakaryocytic and erythrocytic lineages share specific transcription factors. Nature 344: 447-449.
12. Zon, L. I., M. F. Gurish, R. L. Stevens, C. Mather, D. S. Reynolds, K. F. Austen, and S. H. Orkin. 1991. GATA-binding transcription factors in mast cells regulate the promoter of the mast cell carboxypeptidase A gene. J. Biol. Chem. 266: 22948-22953. (Pubitemid 21908743)
13. Zon, L. I., Y. Yamaguchi, K. Yee, E. A. Albee, A. Kimura, J. C. Bennett, S. H. Orkin, and S. J. Ackerman. 1993. Expression of mRNA for the GATAbinding proteins in human eosinophils and basophils: potential role in gene transcription. Blood 81: 3234-3241. (Pubitemid 23172904)
14. Harigae, H., S. Takahashi, N. Suwabe, H. Ohtsu, L. Gu, Z. Yang, F. Y. Tsai, Y. Kitamura, J. D. Engel, and M. Yamamoto. 1998. Differential roles of GATA-1 and GATA-2 in growth and differentiation of mast cells. Genes Cells 3: 39-50. (Pubitemid 28374996)
15. Yu, C., A. B. Cantor, H. Yang, C. Browne, R. A. Wells, Y. Fujiwara, and S. H. Orkin. 2002. Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J. Exp. Med. 195: 1387-1395. (Pubitemid 34602816)
16. Kulessa, H., J. Frampton, and T. Graf. 1995. GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts. Genes Dev. 9: 1250-1262.
17. Hirasawa, R., R. Shimizu, S. Takahashi, M. Osawa, S. Takayanagi, Y. Kato, M. Onodera, N. Minegishi, M. Yamamoto, K. Fukao, et al. 2002. Essential and instructive roles of GATA factors in eosinophil development. J. Exp. Med. 195: 1379-1386. (Pubitemid 34602815)
18. Yamaguchi, Y., S. J. Ackerman, N. Minegishi, M. Takiguchi, M. Yamamoto, and T. Suda. 1998. Mechanisms of transcription in eosinophils: GATA-1, but not GATA-2, transactivates the promoter of the eosinophil granule major basic protein gene. Blood 91: 3447-3458. (Pubitemid 28193898)
19. McNagny, K. M., M. H. Sieweke, G. Do? derlein, T. Graf, and C. Nerlov. 1998. Regulation of eosinophil-specific gene expression by a C/EBP-Ets complex and GATA-1. EMBO J. 17: 3669-3680. (Pubitemid 28327385)
20. Dyer, K. D., and H. F. Rosenberg. 2000. Shared features of transcription: mutational analysis of the eosinophil/basophil Charcot-Leyden crystal protein gene promoter. J. Leukoc. Biol. 67: 691-698.
21. Yang, D., S. Suzuki, L. J. Hao, Y. Fujii, A. Yamauchi, M. Yamamoto, M. Nakamura, and A. Kumatori. 2000. Eosinophil-specific regulation of gp91 (phox) gene expression by transcription factors GATA-1 and GATA-2. J. Biol. Chem. 275: 9425-9432. (Pubitemid 30185169)
22. Kim, B. S., T. G. Uhm, S. K. Lee, S. H. Lee, J. H. Kang, C. S. Park, and I. Y. Chung. 2010. The crucial role of GATA-1 in CCR3 gene transcription: modulated balance by multiple GATA elements in the CCR3 regulatory region. J. Immunol. 185: 6866-6875.
23. Migliaccio, A. R., R. A. Rana, M. Sanchez, R. Lorenzini, L. Centurione, L. Bianchi, A. M. Vannucchi, G. Migliaccio, and S. H. Orkin. 2003. GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA- 1low mouse mutant. J. Exp. Med. 197: 281-296. (Pubitemid 36184235)
24. Maeda, K., C. Nishiyama, T. Tokura, Y. Akizawa, M. Nishiyama, H. Ogawa, K. Okumura, and C. Ra. 2003. Regulation of cell type-specific mouse Fc epsilon RI beta-chain gene expression by GATA-1 via four GATA motifs in the promoter. J. Immunol. 170: 334-340. (Pubitemid 36026157)
25. Tsai, F. Y., and S. H. Orkin. 1997. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood 89: 3636-3643.
26. Walsh, J. C., R. P. DeKoter, H. J. Lee, E. D. Smith, D. W. Lancki, M. F. Gurish, D. S. Friend, R. L. Stevens, J. Anastasi, and H. Singh. 2002. Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates. Immunity 17: 665-676. (Pubitemid 35351511)
27. Dobson, J. T., J. Seibert, E. M. Teh, S. Da'as, R. B. Fraser, B. H. Paw, T. J. Lin, and J. N. Berman. 2008. Carboxypeptidase A5 identifies a novel mast cell lineage in the zebrafish providing new insight into mast cell fate determination. Blood 112: 2969-2972.
28. Pevny, L., C. S. Lin, V. D'Agati, M. C. Simon, S. H. Orkin, and F. Costantini. 1995. Development of hematopoietic cells lacking transcription factor GATA-1. Development 121: 163-172.
29. Ma, P., R. S. Mali, V. Munugalavadla, S. Krishnan, B. Ramdas, E. Sims, H. Martin, J. Ghosh, S. Li, R. J. Chan, et al. 2011. The PI3K pathway drives the maturation of mast cells via microphthalmia transcription factor. Blood 118: 3459-3469.
30. Iwasaki, H., S. Mizuno, Y. Arinobu, H. Ozawa, Y. Mori, H. Shigematsu, K. Takatsu, D. G. Tenen, and K. Akashi. 2006. The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages. Genes Dev. 20: 3010-3021. (Pubitemid 44771735)
31. Qiu, Z., K. D. Dyer, Z. Xie, M. Rådinger, and H. F. Rosenberg. 2009. GATA transcription factors regulate the expression of the human eosinophil-derived neurotoxin (RNase 2) gene. J. Biol. Chem. 284: 13099-13109.
32. Zheng, W., and R. A. Flavell. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89: 587-596. (Pubitemid 27511769)
33. Vijh, S., D. E. Dayhoff, C. E. Wang, Z. Imam, P. K. Ehrenberg, and N. L. Michael. 2002. Transcription regulation of human chemokine receptor CCR3: evidence for a rare TATA-less promoter structure conserved between drosophila and humans. Genomics 80: 86-95. (Pubitemid 34701410)
34. Uhm, T. G., S. K. Lee, B. S. Kim, J. H. Kang, C. S. Park, T. Y. Rhim, H. S. Chang, J. Kim, and I. Y. Chung. 2012. CpG methylation at GATA elements in the regulatory region of CCR3 positively correlates with CCR3 transcription. Exp. Mol. Med. 44: 268-280.
35. Ochi, H., W. M. Hirani, Q. Yuan, D. S. Friend, K. F. Austen, and J. A. Boyce. 1999. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J. Exp. Med. 190: 267-280. (Pubitemid 29354919)
36. Fayyad-Kazan, H., R. Rouas, M. Merimi, N. El Zein, P. Lewalle, F. Jebbawi, M. Mourtada, H. Badran, M. Ezzeddine, B. Salaun, et al. 2010. Valproate treatment of human cord blood CD4-positive effector T cells confers on them the molecular profile (microRNA signature and FOXP3 expression) of natural regulatory CD4-positive cells through inhibition of histone deacetylase. J. Biol. Chem. 285: 20481-20491.
37. Maeda, K., C. Nishiyama, T. Tokura, H. Nakano, S. Kanada, M. Nishiyama, K. Okumura, and H. Ogawa. 2006. FOG-1 represses GATA-1-dependent FcepsilonRI beta-chain transcription: transcriptional mechanism of mast-cellspecific gene expression in mice. Blood 108: 262-269. (Pubitemid 43990637)
38. Guo, Y., P. Xiao, S. Lei, F. Deng, G. G. Xiao, Y. Liu, X. Chen, L. Li, S. Wu, Y. Chen, et al. 2008. How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes. Acta Biochem. Biophys. Sin. 40: 426-436. (Pubitemid 351704046)
39. Dorfman, D. M., D. B. Wilson, G. A. Bruns, and S. H. Orkin. 1992. Human transcription factor GATA-2. Evidence for regulation of preproendothelin-1 gene expression in endothelial cells. J. Biol. Chem. 267: 1279-1285.
40. Du, J., M. J. Stankiewicz, Y. Liu, Q. Xi, J. E. Schmitz, J. A. Lekstrom-Himes, and S. J. Ackerman. 2002. Novel combinatorial interactions of GATA-1, PU.1, and C/EBPepsilon isoforms regulate transcription of the gene encoding eosinophil granule major basic protein. J. Biol. Chem. 277: 43481-43494. (Pubitemid 35285737)
41. Crispino, J. D., M. B. Lodish, J. P. MacKay, and S. H. Orkin. 1999. Use of altered specificity mutants to probe a specific protein-protein interaction in differentiation: the GATA-1:FOG complex. Mol. Cell 3: 219-228. (Pubitemid 29292622)
42. Price, K. S., D. S. Friend, E. A. Mellor, N. De Jesus, G. F. Watts, and J. A. Boyce. 2003. CC chemokine receptor 3 mobilizes to the surface of human mast cells and potentiates immunoglobulin E-dependent generation of interleukin 13. Am. J. Respir. Cell Mol. Biol. 28: 420-427. (Pubitemid 36399363)
43. Fujiwara, T., H. O'Geen, S. Keles, K. Blahnik, A. K. Linnemann, Y. A. Kang, K. Choi, P. J. Farnham, and E. H. Bresnick. 2009. Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy. Mol. Cell 36: 667-681.
44. Bresnick, E. H., H. Y. Lee, T. Fujiwara, K. D. Johnson, and S. Keles. 2010. GATA switches as developmental drivers. J. Biol. Chem. 285: 31087-31093.
45. Uhm, T. G., B. S. Kim, and I. Y. Chung. 2012. Eosinophil development, regulation of eosinophil-specific genes, and role of eosinophils in the pathogenesis of asthma. Allergy Asthma Immunol. Res. 4: 68-79.
46. Mori, Y., H. Iwasaki, K. Kohno, G. Yoshimoto, Y. Kikushige, A. Okeda, N. Uike, H. Niiro, K. Takenaka, K. Nagafuji, et al. 2009. Identification of the human eosinophil lineage-committed progenitor: revision of phenotypic definition of the human common myeloid progenitor. J. Exp. Med. 206: 183-193.
47. Iwasaki, H., S. Mizuno, R. Mayfield, H. Shigematsu, Y. Arinobu, B. Seed, M. F. Gurish, K. Takatsu, and K. Akashi. 2005. Identification of eosinophil lineagecommitted progenitors in the murine bone marrow. J. Exp. Med. 201: 1891-1897. (Pubitemid 41002925)
48. Yamamoto, M., L. J. Ko, M. W. Leonard, H. Beug, S. H. Orkin, and J. D. Engel. 1990. Activity and tissue-specific expression of the transcription factor NF-E1 multigene family. Genes Dev. 4: 1650-1662.
49. Pai, S. Y., M. L. Truitt, C. N. Ting, J. M. Leiden, L. H. Glimcher, and I. C. Ho. 2003. Critical roles for transcription factor GATA-3 in thymocyte development. Immunity 19: 863-875.
50. Samson, S. I., O. Richard, M. Tavian, T. Ranson, C. A. Vosshenrich, F. Colucci, J. Buer, F. Grosveld, I. Godin, and J. P. Di Santo. 2003. GATA-3 promotes maturation, IFN-gamma production, and liver-specific homing of NK cells. Immunity 19: 701-711. (Pubitemid 37490795)
51. Wang, Y., M. A. Su, and Y. Y. Wan. 2011. An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immunity 35: 337-348.
52. Takahashi, S., R. Shimizu, N. Suwabe, T. Kuroha, K. Yoh, J. Ohta, S. Nishimura, K. C. Lim, J. D. Engel, and M. Yamamoto. 2000. GATA factor transgenes under GATA-1 locus control rescue germline GATA-1 mutant deficiencies. Blood 96: 910-916. (Pubitemid 30616855)
53. Kobayashi-Osaki, M., O. Ohneda, N. Suzuki, N. Minegishi, T. Yokomizo, S. Takahashi, K. C. Lim, J. D. Engel, and M. Yamamoto. 2005. GATA motifs regulate early hematopoietic lineage-specific expression of the Gata2 gene. Mol. Cell. Biol. 25: 7005-7020. (Pubitemid 41105900)
54. Pal, S., A. B. Cantor, K. D. Johnson, T. B. Moran, M. E. Boyer, S. H. Orkin, and E. H. Bresnick. 2004. Coregulator-dependent facilitation of chromatin occupancy by GATA-1. Proc. Natl. Acad. Sci. USA 101: 980-985. (Pubitemid 38160570)
55. Tsang, A. P., J. E. Visvader, C. A. Turner, Y. Fujiwara, C. Yu, M. J. Weiss, M. Crossley, and S. H. Orkin. 1997. FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation. Cell 90: 109-119. (Pubitemid 28009423)
56. Querfurth, E., M. Schuster, H. Kulessa, J. D. Crispino, G. Döderlein, S. H. Orkin, T. Graf, and C. Nerlov. 2000. Antagonism between C/EBPbeta and FOG in eosinophil lineage commitment of multipotent hematopoietic progenitors. Genes Dev. 14: 2515-2525.
57. Cantor, A. B., H. Iwasaki, Y. Arinobu, T. B. Moran, H. Shigematsu, M. R. Sullivan, K. Akashi, and S. H. Orkin. 2008. Antagonism of FOG-1 and GATA factors in fate choice for the mast cell lineage. J. Exp. Med. 205: 611-624. (Pubitemid 351439308)
58. Finotto, S., G. T. De Sanctis, H. A. Lehr, U. Herz, M. Buerke, M. Schipp, B. Bartsch, R. Atreya, E. Schmitt, P. R. Galle, et al. 2001. Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression. J. Exp. Med. 193: 1247-1260. (Pubitemid 32524775)
59. Sel, S., M. Wegmann, T. Dicke, S. Sel, W. Henke, A. O. Yildirim, H. Renz, and H. Garn. 2008. Effective prevention and therapy of experimental allergic asthma using a GATA-3-specific DNAzyme. J. Allergy Clin. Immunol. 121: 910-916, e5.